{"id":"W4416554466","doi":"10.14309/crj.0000000000001900","title":"Vedolizumab as a Second Line Biologic for Cronkhite Canada Syndrome and an Approach Toward Disease Monitoring","year":2025,"lang":"en","type":"article","venue":"ACG Case Reports Journal","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Vedolizumab; Infliximab; Inflammatory bowel disease; Endoscopy; Disease; Crohn's disease; Ulcerative colitis; First line","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003457919,0.0002011282,0.0003561139,0.0001214285,0.0002223798,0.0000646008,0.0000468383,0.00009093888,0.00008048032],"category_scores_gemma":[0.0004496645,0.0001619777,0.0000851861,0.0001291038,0.0000627797,0.00007808089,0.00005718475,0.0003353375,1.554071e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004227902,"about_ca_system_score_gemma":0.002317239,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007214441,"about_ca_topic_score_gemma":0.00217136,"domain_scores_codex":[0.9985229,0.00003921439,0.0004957806,0.0003702297,0.0002311684,0.0003407011],"domain_scores_gemma":[0.9986268,0.00006882274,0.0002172925,0.0003079375,0.0002067562,0.0005723518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.001491272,0.0003314981,0.2193622,0.001407353,0.0006710557,0.7497711,0.0004160357,0.0002774092,0.003358416,0.00001801038,0.002956621,0.01993903],"study_design_scores_gemma":[0.001413391,0.0008535361,0.07062463,0.0002529859,0.0004528617,0.9140192,0.0006981617,0.0003063489,0.001909924,0.000825734,0.008331433,0.0003117745],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933286,0.00369151,0.000266225,0.0003637471,0.001415853,0.0004842467,0.00001901954,0.00002274953,0.000408034],"genre_scores_gemma":[0.9964467,0.00007450804,0.001910855,0.0002339112,0.0003879026,0.00005238169,0.00001296878,0.00002161492,0.0008592031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1642481,"threshold_uncertainty_score":0.9993966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03109137628974488,"score_gpt":0.3239484346213108,"score_spread":0.2928570583315659,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}